TD Asset Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,517
| Closed | -$187K | – | 1389 |
|
|
2017
Q1 | $187K | Sell |
1,517
-1,341
| -47% | -$165K | ﹤0.01% | 1378 |
|
|
2016
Q4 | $389K | Sell |
2,858
-290
| -9% | -$39.5K | ﹤0.01% | 1240 |
|
|
2016
Q3 | $626K | Sell |
3,148
-270
| -8% | -$53.7K | ﹤0.01% | 1114 |
|
|
2016
Q2 | $443K | Sell |
3,418
-30
| -0.9% | -$3.89K | ﹤0.01% | 1152 |
|
|
2016
Q1 | $322K | Sell |
3,448
-120
| -3% | -$11.2K | ﹤0.01% | 1213 |
|
|
2015
Q4 | $723K | Sell |
3,568
-1,260
| -26% | -$255K | ﹤0.01% | 1013 |
|
|
2015
Q3 | $701K | Buy |
4,828
+1,438
| +42% | +$209K | ﹤0.01% | 995 |
|
|
2015
Q2 | $721K | Buy |
3,390
+1,920
| +131% | +$408K | ﹤0.01% | 1034 |
|
|
2015
Q1 | $341K | Buy |
1,470
+420
| +40% | +$97.4K | ﹤0.01% | 1210 |
|
|
2014
Q4 | $242K | Buy |
+1,050
| New | +$242K | ﹤0.01% | 1285 |
|